Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 217887
wau-logo.gif

Article ID: 717608

Children with Mild Asthma Can Use Inhalers as Needed

Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis supports evidence that children with mild asthma can effectively manage the condition by using their two inhalers — one a steroid and the other a bronchodilator — when symptoms occur. This is in contrast to the traditional method of using the steroid daily, regardless of symptoms, and the bronchodilator when symptoms occur. The as-needed use of both inhalers is just as effective for mild asthma as the traditional protocol, according to the investigators.

Released:
16-Aug-2019 4:15 PM EDT
Open in New Tab
Comment
Embargo will expire:
22-Aug-2019 5:00 PM EDT
Released to reporters:
16-Aug-2019 4:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Aug-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
20-Aug-2019 11:00 AM EDT
Released to reporters:
16-Aug-2019 4:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Aug-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Bioenergy startup licenses ORNL food-waste-to-fuel system

Article ID: 717602

Bioenergy startup licenses ORNL food-waste-to-fuel system

Oak Ridge National Laboratory

Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.

Released:
16-Aug-2019 2:30 PM EDT
Open in New Tab
Comment
Newswise: Study reveals how stress can curb the desire to eat in an animal model

Article ID: 717601

Study reveals how stress can curb the desire to eat in an animal model

University of Texas Health Science Center at Houston

Eating disorder researchers at The University of Texas Health Science Center at Houston (UTHealth) have discovered a neurocircuit in mice that, when activated, increased their stress levels while decreasing their desire to eat. Findings appear in Nature Communications.

Released:
16-Aug-2019 2:20 PM EDT
Open in New Tab
Comment
Newswise: UTHealth launches dentist-to-dentist ‘telementoring’ program

Article ID: 717603

UTHealth launches dentist-to-dentist ‘telementoring’ program

University of Texas Health Science Center at Houston

Kuwaiti dentist Alaa Al-Saffar, DDS, may be 7,000 miles from the Texas Medical Center but that did not keep her from catching a lecture on mouth ulcers at The University of Texas Health Science Center at Houston (UTHealth).

Released:
16-Aug-2019 2:05 PM EDT
Open in New Tab
Comment

Channels:

Healthcare, Oral Health

Languages:

English

Newswise: UTHealth's Louise McCullough earns 2019 Landis Award for Outstanding Mentorship

Article ID: 717600

UTHealth's Louise McCullough earns 2019 Landis Award for Outstanding Mentorship

University of Texas Health Science Center at Houston

Louise McCullough, MD, PhD, professor and chair of neurology at The University of Texas Health Science Center at Houston (UTHealth), has received the 2019 Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS).

Released:
16-Aug-2019 2:05 PM EDT
Open in New Tab
Comment

Channels:

Healthcare

Languages:

English

Embargo will expire:
19-Aug-2019 11:00 AM EDT
Released to reporters:
16-Aug-2019 1:45 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Aug-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-Aug-2019 5:00 AM EDT
Released to reporters:
16-Aug-2019 1:35 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Aug-2019 5:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study Finds Lack of Racial Diversity in Cancer Drug Clinical Trials

Article ID: 717545

Study Finds Lack of Racial Diversity in Cancer Drug Clinical Trials

Baylor University

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. It raises concerns about the effectiveness of cancer drugs in some patients, especially since genetic differences may affect how a patient responds to a drug.

Released:
16-Aug-2019 12:45 PM EDT
Open in New Tab
Comment

Showing results

110 of 217887

Chat now!